Hope for new Alzheimer's drug from Saxony-Anhalt
Probiodrug is pushing ahead with the development of its business in the United States The biopharmaceutical company Probiodrug from Halle/Saale, Saxony-Anhalt, is researching new approaches into fighting Alzheimer's disease. Probiodrug has been listed on the Euronext stock exchange in Amsterdam since 2014. The company has successfully developed a new therapy concept for diabetics in the past. Since 2007, no new drug has been approved for the treatment of Alzheimer's disease. The medical products currently available only treat the symptoms. "They improve the transmission of